Factors Influencing Risk of Progression of Chronic Kidney Disease

Centre Hospitalier Universitaire de Besancon1,300 enrolled

Overview

The aim of this study is to identify typical patterns of renal function evolution in patients with stage 4 chronic kidney disease, regularly followed in nephrology consultation and included in a French cohort.

Study Type

OBSERVATIONAL

Enrollment

1,300

Conditions

Chronic Kidney Disease stage4

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients meeting the inclusion criteria of the ND-CRIS cohort (long-term follow-up in one of the centers participating in the research, with a GFR \<60mL/min /1.73m2) * Patients included in the ND-CRIS cohort on the date when the estimate of their GFR is strictly less than 30mL/min/1.73m2 and greater than or equal to 15mL/min/1.73m2 (MDRD equation). Patients should have at least two measurements of GFR \<30mL/min/1.73m2 to be included, at least one of them greater than or equal to 15mL/min/1.73m2. The date of the first GFR \<30mL/min/ 1.73m2 will be considered as the date of origin. Exclusion Criteria: * Patients with GFR ≥30mL / min / 1.73m2 or \<15mL / min / 1.73m2 * Patients who do not meet the inclusion criteria of ND-CRIS cohort (dialysis patients, transplant patients, unfollowed patients)

Locations (1)

Centre Hospitalier Universitaire de Besançon

Besançon, France

Outcomes

Primary Outcomes

Evolution of estimated Glomerular Filtration Rate (GFR) according to MDRD equation (modification of diet in renal disease) at each visit

Time frame: up to 3 years

Time between inclusion and occurrence of the "progression" event

progression: initiation of an extra-renal purification technique or reduction of GFR of at least 5 mL / min / 1.73m2 compared to inclusion in FAIR-PROGRESS

Time frame: up to 3 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.